Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home /
  2. News /
  3. Caring & giving /
  4. 5 things to know about how Johnson & Johnson is helping kids with intestinal worms
5-things-to-know-about-how-johnson-johnson-is-helping-kids-with-intestinal-worms-lede-0122.jpg
Photo courtesy of BRAC

5 things to know about how Johnson & Johnson is helping kids with intestinal worms

For World Neglected Tropical Diseases Day, check out a video highlighting the company’s commitment to caring for children with these common infections across the globe.

Photo courtesy of BRAC

In 2012, Johnson & Johnson joined other pharmaceutical companies and organizations, including the Bill & Melinda Gates Foundation, to endorse the London Declaration on Neglected Tropical Diseases (NTDs) . As part of this commitment, companies pledged to donate existing treatments—such as mebendazole, Johnson & Johnson’s medicine for soil-transmitted helminths (STH), or intestinal worm infections—and develop new tools to help combat these infections.

STH infections are among the most common infections around the globe and result from being exposed to contaminated soil, food or water in areas with poor sanitation. Children are particularly vulnerable to the infection, which can lead to malnutrition, stunted growth and even impaired cognitive development.

To help protect kids ages 1 and older against the infection, the Janssen Pharmaceutical Companies of Johnson & Johnson developed a chewable formulation of mebendazole that, when mixed with a small amount of water, turns into a soft mass and is easier for very young children to swallow.

Ten years after the landmark London Declaration, here’s a look at how the company is ensuring that mebendazole is accessible to those who need it.

poster.jpg
5 Things to Know About How Johnson & Johnson is Helping Kids With Intestinal Worms

Johnson & Johnson aims to advance health around the world

Read about more ways the company is helping to solve complex global health challenges, from HIV to Ebola.
Giving Back : Ebola

More from Johnson & Johnson

Introducing the first and only daily disposable multifocal contact lens for people with astigmatism

A Johnson & Johnson scientist explains how the new Acuvue® Oasys Max 1-Day Multifocal for Astigmatism contact lens also filters blue light, supports the eye’s natural tear film and helps eyes easily switch focus from distance to reading.

What is wAIHA?

Warm autoimmune hemolytic anemia (wAIHA) causes fatigue so profound, it can limit the lives of people who have the condition. Learn more about this rare disease and a potential targeted treatment developed by Johnson & Johnson that’s currently in clinical trials.

Could we be on our way to eliminating cancer for good?

What once seemed like an unattainable goal may soon be within our grasp. Learn how Johnson & Johnson is working toward its vision to create a world without cancer.